Descrição
Lipid profile testing quantifies four core cardiometabolic analytes: total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG). Together, these markers provide the foundation for cardiovascular risk stratification, therapeutic decision-making, and longitudinal monitoring.
For near-patient workflows, lipid testing is highly actionable: the panel can be used for baseline screening, therapy initiation, response monitoring, and adherence conversations in pharmacy and outpatient settings.
For near-patient workflows, lipid testing is highly actionable: the panel can be used for baseline screening, therapy initiation, response monitoring, and adherence conversations in pharmacy and outpatient settings.
